Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pharma Deals With The DOJ

Sep 14 2016

• By Brenda Sandburg

Related Content

Teva False Claims Settlement Stems From Kickbacks To Single Doctor

Mar 12 2014

Government Briefs: White House Moves On Patent Reform, DOJ Settles Endo Off-Label Complaints

Feb 24 2014

The Era Of Billion Dollar Pharma Settlements

Jun 11 2012

Pfizer Protonix Settlement May Deter Price Bundling

Feb 16 2016

Does Former Warner Chilcott Exec’s Arrest Portend More Prosecutions?

Nov 02 2015

AstraZeneca Settles Nexium Kickback Suit; Deals Prohibiting Authorized Generic Sales Alleged

Feb 11 2015

Off-Label Convictions Of Device Execs Could Impact Pharma Sales Reps

Jul 23 2016

Pharma Pricing, Non-Profit Ties Get Increasing Scrutiny From Prosecutors

Sep 14 2016

Wyeth Rapamune Off-Label Marketing Settlement Will Not Alter Pfizer’s CIA

Jul 31 2013

J&J Risperdal Off-Label Settlement Includes Exec Pay Recoupment Provision

Nov 05 2013

Tarceva Off-Label Marketing Caused 'Earlier' Death, DOJ Alleged

Jun 10 2016

Ranbaxy’s $500 Million Settlement Includes Criminal Penalties

May 14 2013

Related Companies

GSK plc

Eli Lilly and Company

Pfizer Inc.

Abbott

Johnson & Johnson

Additional Topics

Policy Legal Issues BioPharmaceutical

More from Legal & IP

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window